Emcure Pharmaceuticals Limited — Important, 21-06-2025: Updates

Emcure Pharmaceuticals has announced a board meeting outcome approving requests from multiple promoter group members to reclassify themselves as public shareholders. These members do not currently hold any equity shares. The company will seek necessary approvals from stock exchanges and members to effect this reclassification. This move could increase public float and potentially enhance stock liquidity.